Evidence map›Paper›PMID 41137183›Full record

ArticleJournal of health, population, and nutrition2025

Determinants of uptake of deworming medication during pregnancy in Tanzania: insights from 2022 demographic and health survey.

Vivian P Mushi, Pankras Luoga, Elia Nyangi, Valeria Silvestri, Jiayan Huang

Abstract read
In one paragraph

Article in Journal of health, population, and nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vivian P Mushi *Department of Parasitology and Medical Entomology, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. vmushi31@gmail.com.
Pankras Luoga *Department of Development Studies, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Elia NyangiDepartment of Development Studies, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Valeria SilvestriDepartment of Parasitology and Medical Entomology, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Jiayan HuangSchool of Public Health, Global Health Institute, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAnemia during pregnancy increases delivery risks, with untreated parasitic infections being a major cause. In Tanzania, evidence on deworming uptake among pregnant women aged 15-49 is limited. This study assessed national uptake and determinants of deworming medication use in this group.

methodsWe analyzed secondary data from the 2022 Tanzania Demographic and Health Survey (TDHS-2022), using the Pregnancy Outcome and Care for Pregnancies (NR) file. The study population consisted of pregnant women aged 15-49 years who had a live birth or stillbirth in the three years preceding the survey. A total of 4,401 women were included (unweighted n = 4,387; weighted n = 4,401). The outcome was uptake of deworming medication during pregnancy, defined using DHS variable m60 (yes = 1, no = 0). Survey-adjusted logistic regression was used to identify determinants, and results are presented as adjusted odds ratios (aORs) with 95% confidence intervals (CIs).

resultsThe uptake of deworming medication among pregnant women in Tanzania was 61.9% (95%CI: 59.7-64.0). Multivariable logistic regression analysis revealed several significant determinants. Women aged 25-34 years (aOR: 1.36, 95%CI: 1.13-1.63), residing in the Southern zone (aOR: 1.62, 95%CI: 1.26-2.09), currently employed (aOR: 1.26, 95%CI: 1.08-1.49), and those from wealthier households (aOR: 1.38, 95%CI: 1.05-1.82) had higher odds of taking deworming medication. Insurance coverage (aOR: 1.58, 95%CI: 1.00-2.50), having seven or more children under five years (aOR: 2.80, 95%CI: 1.26-6.23), attending four or more ANC visits (aOR: 1.36, 95%CI: 1.05-1.77), and accessing mass media at least once a week (aOR: 1.40, 95%CI: 1.15-1.72) were also associated with increased uptake. Conversely, women in rural areas had lower odds of taking deworming medication (aOR: 0.75, 95%CI: 0.59-0.95) compared to their urban counterparts.

conclusionsIn Tanzania, deworming medication uptake among pregnant women remains suboptimal. Determinants of higher uptake included age 25-34 years, southern residence, employment, wealth, insurance coverage, high parity, attending at least four ANC visits, and regular media exposure, while rural residence was associated with lower uptake. ANC programmes should prioritize equitable access and implement tailored strategies to improve coverage, particularly among rural and underserved women.

Indexed as

Antiparasitic AgentsPatient Acceptance of Health CarePregnancy Complications, ParasiticPrenatal CareSocial Determinants of HealthAdolescentAdultCross-Sectional StudiesDemographyFemaleHumansLive BirthLogistic ModelsMiddle AgedOdds RatioPregnancyAntiparasitic AgentsAnemiaDewormingPregnant womenTanzania Demographic Health Survey

Identifiers

PMID41137183
PMCPMC12553271

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.